First-line encorafenib plus binimetinib and pembrolizumab for advanced BRAF V600-mutant melanoma: Safety lead-in results from the randomized phase III STARBOARD study
| Autor: | Dudnichenko, Oleksandr, Penkov, Konstantin, McKean, Meredith, Mandalà, Mario, Kukushkina, Mariia, Panella, Timothy, Csőszi, Tibor, Gerletti, Paola, Thakur, Mahgull, Polli, Anna, di Pietro, Alessandra, Schadendorf, Dirk |
|---|---|
| Zdroj: | In European Journal of Cancer December 2024 213 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect